Deutsche Bank Ag\ Stealth Bio Therapeutics Corp Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.23 - $2.22 $12,054 - $21,756	-9,800 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.97 - $3.13 $9,506 - $30,674	9,800 New	9,800 $12,000
Q4 2019 Feb 14, 2020	SELL	$3.26 - $13.7 $1,134 - $4,767	-348 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.22 - $13.36 $694 - $1,776	133 Added 61.86%	348 $2,000
Q2 2019 Aug 14, 2019	BUY	$11.67 - $15.45 $2,509 - $3,321	215 New	215 $2,000

2.94K

Ticker MITO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,548,600
Description
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.